on the Differential Diagnosis of Obsessive-compulsive Symptoms in Schizophrenia: A Conceptual and Clinical Analysis

2009 ◽  
Vol 24 (S1) ◽  
pp. 1-1
Author(s):  
P. Michalopoulou ◽  
P. Oulis ◽  
G. Konstantakopoulos ◽  
L. Lykouras

Several shortcomings of the current psychodiagnostic manuals (DSM-IV, ICD-10) with respect to obsessive-compulsive disorder, such as the diagnostic parity of obsessions and compulsions and the deficient conceptualization of compulsions might artificially inflate the clinical prevalence of obsessive-compulsive (OC) symptoms in the course of schizophrenic disorders. Still, one cannot exclude on purely a priori grounds the possibility of a genuine coexistence of OC symptoms along with delusions in patients with schizophrenia. the aim of the present study was to provide a contrastive conceptual analysis of typical features of obsessions versus those of delusions and correlatively of compulsions versus delusionally-motivated repetitive behaviours, supplemented by four relevant vignettes as clinical tests of its adequacy. Although preliminary, the results of our conceptual and illustrative analyses suggest that General Psychopathology can afford the conceptual resources for the accurate differential diagnosis obsession/compulsions from delusions/delusionally-motivated repetitive behaviours. in turn, this would provide a more solid clinical ground for the investigation of the epidemiology and the pathophysiology of OC symptoms in schizophrenic disorders.

1991 ◽  
Vol 6 (6) ◽  
pp. 307-314 ◽  
Author(s):  
A Frances ◽  
W Wakefield Davis ◽  
M Kline ◽  
H Pincus ◽  
M First ◽  
...  

SummaryThe authors present an overview of the process for developing DSM IV which has been characterized by extensive international communication and collaboration and which includes three stages of empirical review: systematic literature reviews, analysis of unpublished data and field trials. Next, they describe in detail recently initiated DSM IV field trials. The field trials will study eleven diagnostic categories which continue to be the focus of much discussion. They include antisocial personality disorder, autism, disruptive disorders, dysthymia, insomnia, mixed anxiety and depression, obsessive-compulsive disorder, posttraumatic stress disorder, schizophrenia, somatoform disorder and substance use disorders. Each field trial compares the DSM III, the DSM III-R, ICD 10 and proposed DSM IV criteria for the disorder in question.


Author(s):  
Philip Cowen ◽  
Paul Harrison ◽  
Tom Burns

Chapter 9 discusses how the symptom of anxiety is found in many disorders. In the anxiety disorders, it is the most severe and prominent symptom, and it is also prominent in the obsessional disorders, although these are characterizedby their striking obsessional symptoms. In DSM-IV, obsessive–compulsive disorder is classifi ed as a type of anxiety disorder, but in ICD-10 it is classified separately. We have followed the DSM convention and included obsessional disorders in this chapter, as well as covering generalized anxiety disorder (GAD), phobias, panic, mixed anxiety and depression, transcultural variations, and obsessive-compulsive disorder (OCD).


2018 ◽  

People with Obsessive Compulsive Disorder (OCD) experience unpleasant and intrusive thoughts, images, doubts or urges (called obsessions) and repetitive behaviours (called compulsions). Compulsions are usually carried out as a way of reducing the distress caused by obsessions. OCD takes many different forms and causes distress and interference to day-to-day life. 


2012 ◽  
Vol 6 (4) ◽  
pp. 1-6
Author(s):  
B Yengkokpam ◽  
SK Shah ◽  
GR Bhantana

This study was carried out among the patients working abroad and their family members, having various psychiatric disorders. 80 patients attending psychiatry OPD between the age of 15 to 65 years both male and female in the period of July 2009 to July 2010 were included. The results were tabulated as per the diagnostic criteria of International Classification of Diseases (ICD-10). Out of total 80 patients, 41 were males and 39 were females, whose husbands were working abroad. 30 cases were of depression,out of which 16 were males and 14 were females.18 cases were having anxiety disorders out of which 5 were males and 13 were females. 12 cases were suffering from psychotic disorders out of which 10 were males and 2 were females.7 cases were having dissociative disorders with 1 male and 6 females.4 cases were having somatoform disorders with 2 males and 2 females.1 male and 1 female were suffering from mania.1 male and 1 female were suffering from bipolar affective disorder. 2 males were alcohol dependent and 2 males were having obsessive compulsive disorder. 1 male was having organic psychosis. Journal of College of Medical Sciences-Nepal,2011,Vol-6,No-4, 1-6 DOI: http://dx.doi.org/10.3126/jcmsn.v6i4.6718


CNS Spectrums ◽  
1996 ◽  
Vol 1 (2) ◽  
pp. 54-57 ◽  
Author(s):  
Stefano Pallanti ◽  
Lorrin M. Koran

AbstractBody dysmorphic disorder (BDD) is characterized by excessive preoccupation with an imagined or greatly exaggerated defect in appearance, and often by related rituals or pursuit of medical or surgical treatments. The frequent comorbidity of BDD with obsessive-compulsive disorder (OCD) and the phenomenological similarities between these two disorders suggest that they may be related. BDD reportedly responds to oral clomipramine (CMI).We present here two case studies of patients meeting DSM-IV criteria for BDD with comorbid delusional disorder, somatic type, to whom we administered pulse-loaded intravenous (IV) CMI (150 mg on day 1, 200 mg on day 2). After a 4.5-day drug holiday, both patients continued on oral CMI. As reflected in modified Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) scores, both patients' BDD improved by about one third within 4.5 days of the second IV dose. Improvement continued over 2 months on oral CMI, and comorbid major depression present in one patient remitted. By the end of 8 weeks of oral CMI, the patients' modified Y-BOCS scores had decreased about 55%, and their social functioning had markedly improved.As in OCD, pulse-loaded, IV CMI may produce a much faster response than oral CMI or selective serotonin reuptake treatment and can be well tolerated. This treatment approach to BDD deserves further study in a prospective, randomized controlled trial.


Sign in / Sign up

Export Citation Format

Share Document